» Authors » Omid Mohamadzadeh

Omid Mohamadzadeh

Explore the profile of Omid Mohamadzadeh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 13
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazar-Atabaki A, Mohamadzadeh O, Sadrehosseini S, Tabari A, Zeinalizadeh M
Clin Case Rep . 2023 Aug; 11(9):e7808. PMID: 37636878
Key Clinical Message: Kidney metastasis to the pituitary gland can cause hyperprolactinemia even above 250 ng/mL. Although the treatment of metastasis is palliative, surgical decompression could play a major role...
2.
Rahimian N, Sheida A, Rajabi M, Heidari M, Tobeiha M, Esfahani P, et al.
Pathol Res Pract . 2023 Jul; 248:154649. PMID: 37453360
Pituitary adenoma (PA) is the third most common primary intracranial tumor in terms of overall disease incidence. Although they are benign tumors, they can have a variety of clinical symptoms,...
3.
Mohamadzadeh O, Hajinouri M, Moammer F, Tamehri Zadeh S, Omid Shafiei G, Jafari A, et al.
Mol Neurobiol . 2023 Apr; 60(7):4064-4083. PMID: 37020123
Nowadays, there is an increasing concern regarding traumatic brain injury (TBI) worldwide since substantial morbidity is observed after it, and the long-term consequences that are not yet fully recognized. A...
4.
Nabizadeh F, Mohamadzadeh O, Hosseini H, Rasouli K, Esmalian Afyouni N
J Clin Neurosci . 2023 Feb; 110:12-18. PMID: 36780781
Background: Studies revealed that serum neurofilament light chain (NFL) levels not only increase considerably over time in Parkinson's disease (PD) but also have a significant association with disease progression. However,...
5.
Hosseinalizadeh H, Mohamadzadeh O, Kahrizi M, Razaghi Bahabadi Z, Klionsky D, Mirzei H
Cell Mol Biol Lett . 2023 Jan; 28(1):6. PMID: 36690946
Glioblastoma multiforme (GBM) is an aggressive primary brain tumor and one of the most lethal central nervous system tumors in adults. Despite significant breakthroughs in standard treatment, only about 5%...
6.
Mohamadzadeh O, Sadrehosseini S, Tabari A, Ghanaati H, Zeinalizadeh M
World Neurosurg . 2023 Jan; 172:e326-e334. PMID: 36640834
Objective: Visual impairment has been reported as the most common clinical manifestation of pituitary adenoma (PA) due to the compressive effect of the tumor. This prospective study aimed to evaluate...